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Abstract
Background: The aim of the study was to assess four evidence-based assessments utilising exercise challenges that
induce breathlessness, each with progressively less demanding levels of exertion, which can be tailored to people
with a range of functional capabilities in the setting of advanced cancer for research studies. Functional cut off
points for these assessments have not previously been defined.
Methods: A cross sectional study of four exercise tests attempted by all participants: 6min walk test (6MWT); (derived) 2
min walk test (2MWT); arm exercises; and reading numbers aloud. Performance status (Australia-modified Karnofsky
Performance Status (AKPS)), baseline breathlessness using the modified Medical Research Council (mMRC) breathlessness
scale, and a visual analogue scale of intensity and unpleasantness of breathlessness were measured. Co-morbidity was
codified using the Charlson Co-morbidity Index. Percentage of people completing each test by AKPS level of function
and baseline mMRC breathlessness scores were quantified.
Results: In the 68 participants, poorer function decreased the proportion of people able to complete the exercise tests.
For completion rates ≥80%, of 6MWT and 2MWT, only people with an AKPS 70–90 had completion. For arm exercises,
this included people with an AKPS as low as ≥50; and for reading numbers, it included people with an AKPS of 40 but
not below.
Conclusions: Walking tests have poor utility in people with high levels of functional impairment. For people with high
levels of dependence, reading numbers should be used in evaluating exercise-induced breathlessness in research
studies. These data also suggest that people’s exertional limitations have been under-estimated as cancer progresses.
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Background
Clinical research of breathlessness may include measur-
ing the subjective symptom’s intensity and unpleasant-
ness, as well as using objective measures of the exercise
that the person can undertake before being stopped
through breathlessness, fatigue or both. The perform-
ance during the test and time to stopping become ob-
jective measures relating to cardio-respiratory function.
In advanced cancer, as physical function expectedly de-
clines with progression of a person’s life-limiting illness,
the exercise tests to induce breathlessness that can be
practically used for research will differ from people with
no functional impairment.
Functional capacity has been extensively explored in
people with cardiopulmonary disease where reasonable
functional status has been maintained. One of the core
methods of objectively assessing how function is limited
by breathlessness, fatigue or both has been with the
6-min walk test (6MWT) [1]. The 6-min walk distance
(6MWD) has become the primary outcome measure
used in pulmonary rehabilitation programs as well as
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chronic heart failure and pulmonary hypertension [1–4].
The 6MWD has been used in clinical research to quan-
tify exercise capacity in people with a range of condi-
tions, including cancer [5–7]. In populations that are
frailer and unable to undertake a 6MWT, there remains
limited use of objective exercise tests to quantify limita-
tions due to breathlessness.
The aim of the study was to assess the use of four
evidence-based exercise tests that induce breathlessness
to define at which levels of function each of these tests
would be best employed. This has not been previously
systematically explored and quantified, with functional
cut off points for these assessments never having been
defined.
Methods
This cross-sectional study was undertaken from Novem-
ber 2010 to October 2015. Given that this was an ex-
ploratory study, a convenience cohort of 68 people were
recruited.
Setting
Participants were recruited from Prince of Wales Hos-
pital Departments of Oncology and Palliative Care,
Randwick, New South Wales; Braeside Hospital Depart-
ment of Palliative Care, Prairiewood, New South Wales;
Southern Adelaide Palliative Services, Daw Park, South
Australia; Calvary Health Care Palliative Care Services,
Kogarah, New South Wales in Australia.
Participants
Participants were eligible for inclusion in the study if
they had a diagnosis of advanced cancer, defined as
metastatic or advanced loco-regional disease, a predicted
survival of greater than 7 days as assessed by the refer-
ring doctor, were over the age of 18, able to give in-
formed consent and were English speaking.
Participants were excluded if they had an Australia-
modified Karnofsky Performance Scale (AKPS) of less
than 20, unstable angina, a documented myocardial in-
farction during the previous 1 month, resting heart rate of
more than 120 beats per minute, systolic blood pressure >
180, diastolic blood pressure > 100 at the time of the test,
an inability to complete bilateral arm exercises or signifi-
cant communication problems. These exclusions were to
ensure safety when completing the walk tests. The ability
to complete bilateral arm exercises and communication
issues were to ensure safety and baseline ability in com-
pleting the arm test and reading number aloud test.
Protocol
The exercise tests were undertaken with participants
once, taking a period of up to 90 min, as participants
had 20 min of rest between each of the tests. Baseline
breathlessness measures and performance status were
recorded. Participants attempted each of the four exer-
cise tests. If they were unable to attempt any of the tests
due to functional limitation, this was recorded. Study
procedures were standardised across all study sites
through education for data collectors on how to complete
each test by the primary investigator. A standard proced-
ure booklet was also provided to each data collector to
follow while undertaking each exercise test, assessment of
breathlessness, performance status and comorbidity.
Exercise tests undertaken
6MWT and 2MWT
The 6MWT was originally developed as a reliable and
reproducible assessment of sub-maximal exercise toler-
ance in respiratory disease [2]. Initially a 12-min walk test
was used, however results were found to be valid and re-
producible with a 6MWT, and a 2-min walk test (2MWT)
was subsequently derived [5, 6]. This study measured
6MWD and 2MWD as the first two levels of exercise
tests. The 6MWT and 2MWT were undertaken using the
Pulmonary Rehabilitation Toolkit protocol [7].
Arm exercises
Wilcock et al [8] developed an upper limb exercise test to
assess breathlessness in people with a cancer diagnosis.
Their research demonstrated this arm exercise test was
able to stimulate breathlessness for use as an outcome
measure to assess the benefit of new treatments to man-
age chronic breathlessness for people living with cancer
[8]. The measurement of this exercise test is with the par-
ticipant moving an outstretched arm between two points
20 cm above and 20 cm below their shoulder height in
time to an audible beat. The participant changes arms at
one-minute intervals until they can no longer continue.
Reading numbers aloud
Reading numbers aloud was developed as an exercise
test to assess breathlessness in people living with cancer
prior to and following medical interventions for their
chronic breathlessness [9]. The measurement of this exer-
cise test is in the number of numbers that can be read
aloud, and the number of breaths taken in a one-minute
period, with the procedure repeated up to 5 times. A
higher number represents a longer time to breathlessness.
Breathlessness measures
The modified Medical Research Council breathlessness
scale (mMRC), an ordinal rating scale of breathlessness,
and a visual analogue scale measuring intensity and un-
pleasantness of breathlessness were used to identify the
level of breathlessness experienced by the participant in
daily life prior to attempting the outcome measures. A
higher score reflects greater breathlessness.
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Performance status
One of the most common clinician-assessed tools used
to identify performance status in people living with
advanced cancer is the Australia-modified Karnofsky
Performance Status (AKPS) [10]. The AKPS correlates
with prognosis in advanced cancer and reflects the level
of physical support people need in their activities of daily
living. AKPS was used in this research to identify per-
formance status of participants at the time of completing
the outcome measures, with a lower AKPS score repre-
senting poorer function.
Co-morbidity
Co-morbidity was codified using the Charlson Co-mor-
bidity Index, a valid and reliable tool that has shown re-
lationships with mortality, disability and length of
hospital stay [11, 12]. This score omitted cancer, as all
participants had a cancer diagnosis.
Statistical analysis
Descriptive statistics were used to describe the popula-
tion. Percentage of people completing each test by level
of function (AKPS) and by baseline breathlessness scores
(mMRC) were quantified, with an arbitrary rate of 80%
accepted as likely to be of utility in clinical research.
Results for each test at each level were then defined, ex-
ploring the absolute values of people able to complete
the test and the standard deviation of the measures
found. No data were imputed.
Results
Sixty eight people participated in the study (28 (42%)
males); median 70 (range 37–93; Table 1). All people
had cancer with primary sites largely reflecting the bur-
den of advanced cancer (lung 19 (28%); prostate 9 (13%);
colon/rectum 7 (10%); breast 6 (9%)). Baseline scores for
breathlessness were measured using the modified Med-
ical Research Council scale (mMRC 0 = 9; mMRC 1 = 13;
mMRC 2 = 16; mMRC 3 = 10; mMRC 4 = 18; two miss-
ing; median 2.0; range 0, 4).
Baseline performance status was measured using the
AKPS (median 60; AKPS 90,80 = 7; AKPS 70 = 8; AKPS
60 = 22; AKPS 50 = 10; AKPS 40 = 17; AKPS 30,20 = 4).
Functionally, the results equate to participants being
able to care for most their activities of daily living, but
requiring occasional assistance.
Co-morbidities related to cardiac or respiratory disease
from Charlson co-morbidity index were relatively infre-
quent; COPD 6 participants; CCF and COPD 3 partici-
pants; CCF 2 participants; and one participant each with
CCF and pulmonary hypertension, hypertension, angina,
and asthma.
As function decreased, the proportion of people able
to attempt the exercise tests declined (Fig. 1). The au-
thors have defined completion across all four exercise
tests as those who attempted each test. A ceiling effect
was noted for people with high function for the reading
numbers and arm exercise tests. For completion of
6MWT and 2MWT, only people with an AKPS 70–90
had completion rates ≥80%. For arm exercises, this in-
cluded people with an AKPS of ≥50; and for reading
numbers, it included people with an AKPS of 40. These
results define at which level of AKPS, that is perform-
ance status, each of the exercise tests is best utilised.
For values gained for people who completed each ex-
ercise test, the largest drops occurred between AKPS 60
and 50 for 6MWT and 2MWT, while for arm exercises
there was no particular pattern of decline in values
achieved by functional status and for reading numbers
aloud. Similar results were seen from people with an
AKPS 20–50.
The primary reasons for participants being unable to
complete or participate in the exercise tests are listed in
Table 2.
As modified Medical Research Council breathlessness
scores increased, the percentage of people able to
complete the exercise tests declined (Fig. 2). For those
people with an mMRC of 4, 20% were able to complete
the 6MWT; 75% the 2MWT; and 40% arm exercises and
reading numbers.
Table 1 Participants’ characteristics in a cohort study of people with advanced cancer
Domain Measure Mean SD Median Range n (%)
Age 69.9 12.7 70.0 37, 93
Gender Male 28 (41)
Body mass index (BMI) 25.1 5.2 24.2 17.0, 41.6
Functional status AKPS 55.0 14.7 60.0 20, 90
Breathlessness mMRC 2.2 1.4 2.0 0, 4
Intensity (NRS; 0–10) 2.7 2.4 2.0 0, 8
Unpleasantness (VAS; 0–100) 25.5 28.2 15.5 0, 100
Co-morbidities CCI 6.4 1.6 6.0 2, 11
SD standard deviation, AKPS Australia-modified Karnofsky Performance Status, ECOG Eastern Co-operative Group performance status, mMRC modified Medical
Research Council breathlessness scale, NRS Numerical Rating Scale, VAS Visual Analogue Scale, CCI Charlson Co-morbidity Index
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Discussion
Three distinct levels of function defined people’s ability
to participate in exercise tests that were expected to be
limited by breathlessness: those who could complete
walking tests (AKPS 70–90); those who could complete
arm exercises (AKPS ≥50) and those who could only
read numbers (AKPS ≥20). This work builds on the test
devised by Wilcock et al. by defining populations for
whom no other test is available. The functional cut off
points for these exercise tests in advanced disease have
not previously been defined.
This is the first study to try and determine which exer-
cise test should be used to assess exertion-induced
breathlessness as functional status declines. Measuring
the level of, or changes in degree of exertion required to
induce breathlessness is important in research about this
symptom in people at the end of life. Percentage com-
pletion rates are an important first step in understanding
the best test to use. Reproducibility of outcomes within
a single level of function becomes the next important
factor to consider and, finally, the ability to see change
between groups as function declines.
Given the findings in this study, in the past, clinicians
may have under-estimated the impact of an individual’s
exertional limitations as function declines. Asking what
people avoid in order to ensure they do not experience
breathlessness is a clinically important question in this
setting.
For future research, the findings of this current study
suggest that if the population whose exertion limited by
breathlessness is being studied includes a relatively large
proportion of people with an AKPS of 20–40, then
Fig. 1 Percentage of completion of 6-min walk test, 2-min walk test, arm exercise and reading numbers by Australian-modified Karnofsky
Performance Scale in 68 people with advanced cancer
Table 2 Reason for participants’ being unable to complete
exercise tests
Outcome measure Reasons for not completing
measure (more than 1 permitted)
n





Lower limb oedema 1





Lower limb oedema 1





Reading numbers Fatigue 5
Breathlessness 2
NB: Participants were able to give multiple reasons for being unable to
exercise tests
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reading numbers would be the tool of choice; if above
40, then arm exercises would be appropriate. Walking
tests are for only for the group of people who are func-
tioning independently.
Limitations
This was a relatively small convenience sample with
understandably limited participation for people with
poorer functional status. These data were only
cross-sectional and a future longitudinal study would
add value to the findings. One challenge of this
clinician-initiated study was the time taken to recruit 68
participants and the even greater challenge of recruiting
people with poor functional status.
Strengths
This is a cohort that represents people with the full
spectrum of function decline seen in the course of ad-
vancing cancer. This is the first such study and the find-
ings confirm the importance of applying commonly used
exercise tests (such as 6MWT) to a population who can
reasonably participate in the measurement.
Implications for clinical care
This study is primarily about reflecting which exercise
tests should be used for assessing the exertion re-
quired to either induce breathlessness or limit func-
tion for clinical research in the future. The most
direct clinical application of these findings is that the
limitations imposed by declining functional status
may well be under-estimated by clinicians. These are
timely data stressing the level of function reflected in
a measure such as the AKPS.
Implications for research
Longitudinal data to assess these same parameters will
allow intra-individual comparisons over time in order to
assess responsiveness to change, and strengthen the
understanding of the choices that should be made in
assessing these patient populations.
Conclusions
The results of this study demonstrate how functionally
limited people are once their AKPS begins to fall. People
become profoundly functionally impaired as disease
progresses. When researching breathlessness in the
population with advanced cancer, this study guides the
choice of test to use at different points along their trajec-
tory of decline through reporting the functional cut off
points for four exercise-based tools.
This study demonstrates the importance of tailoring
objective exercise-induced breathlessness tests to a per-
son’s level of function in future breathlessness research
in life-limiting illness.
Abbreviations
2MWD: 2 min walk distance; 6MWD: 6 min walk distance; 2MWT: 2 min walk
test; 6MWT: 6 min walk test; AKPS: Australia-modified Karnofsky Performance
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